Literature DB >> 19423527

Obesity, weight gain, and risk of chronic myeloid leukemia.

Sara S Strom1, Yuko Yamamura, Hagop M Kantarijian, Jorge E Cortes-Franco.   

Abstract

To date, little is known about the risk factors for the development of chronic myeloid leukemia (CML). Obesity, measured as body mass index, has been identified as a possible risk factor for several solid tumors as well as some adult hematopoietic malignancies. This case-control study (N = 253 cases and 270 controls), conducted at the University of Texas M. D. Anderson Cancer Center, investigated the role of obesity and adulthood weight gain in CML risk. Cases and controls were similar with respect to smoking, alcohol consumption, and occupational solvent and ionizing radiation exposure. Cases were significantly more likely to have a history of occupational exposure to agricultural chemicals (11% cases versus 3% controls, P = 0.001). Cases were more likely to be obese during adulthood compared with controls at age 25 [odds ratios (OR) = 4.29; 95% confidence intervals (95% CI), 1.63-11.3], at age 40 (OR = 5.12; 95% CI, 1.92-13.6), and at diagnosis (OR = 3.09; 95% CI, 1.56-6.13). Obesity at all ages was found to be an independent risk factor, with a significant dose-response effect. Among participants > or =45 years, cases gained significantly more weight each year between ages 25 and 40 compared with controls (0.78 versus 0.44 kg/y, P < 0.001) with the association strongest among those who gained >1 kg/y between 25 and 40 years of age (OR, 3.63; 95% CI, 1.46-9.04). Our results suggest that obesity and adulthood weight gain play important roles in CML risk. Several plausible biological mechanisms have been proposed and warrant further investigation. In the future, cancer prevention interventions aimed at reducing the incidence of CML could be developed.

Entities:  

Mesh:

Year:  2009        PMID: 19423527      PMCID: PMC2918285          DOI: 10.1158/1055-9965.EPI-09-0028

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

1.  Early-age body size, adult weight gain and endometrial cancer risk.

Authors:  L Le Marchand; L R Wilkens; M P Mi
Journal:  Int J Cancer       Date:  1991-07-30       Impact factor: 7.396

2.  Body mass index, weight gain, and risk of endometrial cancer.

Authors:  S H Olson; M Trevisan; J R Marshall; S Graham; M Zielezny; J E Vena; R Hellmann; J L Freudenheim
Journal:  Nutr Cancer       Date:  1995       Impact factor: 2.900

3.  Chronic myeloid leukaemia in Yorkshire: a case control study.

Authors:  P A McKinney; B E Roberts; C O'Brien; C C Bird; I D Richards; F Alexander; R A Cartwright
Journal:  Acta Haematol       Date:  1990       Impact factor: 2.195

4.  Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group.

Authors:  R B Hayes; S N Yin; M Dosemeci; G L Li; S Wacholder; L B Travis; C Y Li; N Rothman; R N Hoover; M S Linet
Journal:  J Natl Cancer Inst       Date:  1997-07-16       Impact factor: 13.506

5.  Effects of three features of a job-exposure matrix on risk estimates.

Authors:  M Dosemeci; P Cocco; M Gómez; P A Stewart; E F Heineman
Journal:  Epidemiology       Date:  1994-01       Impact factor: 4.822

6.  Obesity and cancer risk among white and black United States veterans.

Authors:  Claudine Samanic; Gloria Gridley; Wong-Ho Chow; Jay Lubin; Robert N Hoover; Joseph F Fraumeni
Journal:  Cancer Causes Control       Date:  2004-02       Impact factor: 2.506

7.  Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group.

Authors:  A Mele; M Szklo; G Visani; M A Stazi; G Castelli; P Pasquini; F Mandelli
Journal:  Am J Epidemiol       Date:  1994-03-15       Impact factor: 4.897

8.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

Authors:  D L Preston; S Kusumi; M Tomonaga; S Izumi; E Ron; A Kuramoto; N Kamada; H Dohy; T Matsuo; T ] Matsui T [corrected to Matsuo
Journal:  Radiat Res       Date:  1994-02       Impact factor: 2.841

9.  Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.

Authors:  Maria Dalamaga; Konstantinos Karmaniolas; Athina Nikolaidou; John Chamberland; Alex Hsi; Amalia Dionyssiou-Asteriou; Christos S Mantzoros
Journal:  Eur J Cancer       Date:  2008-08       Impact factor: 9.162

Review 10.  Leptin receptor and leukemia.

Authors:  M Hino; T Nakao; T Yamane; K Ohta; T Takubo; N Tatsumi
Journal:  Leuk Lymphoma       Date:  2000-02
View more
  16 in total

Review 1.  Epidemiology of MPN: what do we know?

Authors:  L A Anderson; M F McMullin
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

2.  The Cancer Drug Dasatinib Increases PGC-1α in Adipose Tissue but Has Adverse Effects on Glucose Tolerance in Obese Mice.

Authors:  Lykke Sylow; Jonathan Z Long; Isha A Lokurkar; Xing Zeng; Erik A Richter; Bruce M Spiegelman
Journal:  Endocrinology       Date:  2016-09-02       Impact factor: 4.736

3.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes.

Authors:  Dongmei Sun; Xiaoying Zhuang; Xiaoyu Xiang; Yuelong Liu; Shuangyin Zhang; Cunren Liu; Stephen Barnes; William Grizzle; Donald Miller; Huang-Ge Zhang
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

4.  Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Jenny N Poynter; Michaela Richardson; Cindy K Blair; Michelle A Roesler; Betsy A Hirsch; Phuong Nguyen; Adina Cioc; Erica Warlick; James R Cerhan; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2015-12-22       Impact factor: 2.984

5.  Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.S.

Authors:  Dai Chihara; Hidemi Ito; Tomohiro Matsuda; Kota Katanoda; Akiko Shibata; Kumiko Saika; Tomotaka Sobue; Keitaro Matsuo
Journal:  Oncologist       Date:  2012-09-12

6.  Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study.

Authors:  Geoffrey C Kabat; Jennifer W Wu; Steven C Moore; Lindsay M Morton; Yikyung Park; Albert R Hollenbeck; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-26       Impact factor: 4.254

Review 7.  The role of adiponectin in cancer: a review of current evidence.

Authors:  Maria Dalamaga; Kalliope N Diakopoulos; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2012-04-30       Impact factor: 19.871

8.  Chronic myelogenous leukemia occurring in two brothers: The opposite sides of the same coin?

Authors:  Evgenia Verrou; Kyriaki Tsirou; Nikolaos Karampatzakis; Theodora Triantafyllou; Aggeliki Sevastoudi; Georgia I Grigoriadou; Pavlina Konstantinidou; Panagiotis Panagiotidis; Eirini Katodritou
Journal:  Leuk Res Rep       Date:  2021-07-31

9.  Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer.

Authors:  Marisa J L Aitken; Christopher B Benton; Ghayas C Issa; Koji Sasaki; Musa Yilmaz; Nicholas J Short
Journal:  Acta Haematol       Date:  2021-03-18       Impact factor: 2.195

10.  Leptin reverts pro-apoptotic and antiproliferative effects of α-linolenic acids in BCR-ABL positive leukemic cells: involvement of PI3K pathway.

Authors:  Aurore Beaulieu; Géraldine Poncin; Zakia Belaid-Choucair; Chantal Humblet; Gordana Bogdanovic; Georges Lognay; Jacques Boniver; Marie-Paule Defresne
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.